Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass

✍ Scribed by P. Hadji, V. Ziller, D. Gamerdinger, W. Spieler, K. Articus, M. Baier, R. Moericke, P. H. Kann

• Book ID: 113021098
• Publisher: Springer-Verlag
• Year: 2011
• Tongue: English
• Weight: 176 KB
• Volume: 23
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/s00198-011-1834-4